Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

DNB

Dun & Bradstreet Acquired for $7.7 Billion

Dun & Bradstreet (NYSE: DNB), a leading global provider of business decisioning data and analytics, has entered into a definitive agreement to be acquired by Clearlake Capital Group, L.P. in a transaction valued at $7.7 billion. Under the terms of the agreement, Dun & Bradstreet shareholders will receive $9.15 in cash for each share of common stock they own. The transaction is expected to close in the third quarter of 2025, subject to shareholder approval and regulatory clearances.

Dun & Bradstreet's CEO, Anthony Jabbour, noted that the company has experienced significant growth and improvement over the last six years. Revenue has grown by approximately 40%, EBITDA by 60%, and margins have expanded by nearly 600 basis points. Additionally, leverage has decreased from 9 times to 3.6 times.

The purchase price for the acquisition will be funded by Clearlake with a combination of equity and debt financing. BofA Securities is serving as the financial advisor to Dun & Bradstreet in this transaction, while Weil, Gotshal & Manges LLP is serving as legal counsel.

Upon completion of the transaction, Dun & Bradstreet will become a privately held company and will no longer be listed on any public market.

Clearlake Capital Group, L.P., founded in 2006, has a sector-focused approach and currently has over $90 billion of assets under management. The firm is headquartered in Santa Monica, CA, and has affiliates in several other locations globally.

The transaction, subject to customary closing conditions, represents a significant development for both Dun & Bradstreet and Clearlake Capital Group, L.P. The market has reacted to these announcements by moving the company's shares -0.3% to a price of $8.96. For the full picture, make sure to review Dun & Bradstreet's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS